Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: 2 recruiting locations
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase1, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: 41 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Creating Health Course Study for People With Rheumatological Conditions
for
Rheumatoid Arthritis, Sjogren's Syndrome,
Location: 1 recruiting location
Sponsor: Terry L. Wahls
Sex: All
Age: 18 - 70+
Code: NCT07180537
Recruiting
Active & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
Location: 12 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 5 - 18
Code: NCT06100744
Phase3, Recruiting
New
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
for
Psoriasis
Location: 5 recruiting locations
Sponsor: Arcutis Biotherapeutics, Inc.
Sex: All
Age: 2 - 12
Code: NCT07340216
Phase1, Recruiting
New
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis